Timothy Malouff
@tmalouff
Followers
334
Following
1K
Media
14
Statuses
108
Dad and Husband. Christian. Assistant Professor @radonc_ou. Fan of all things Disney.
Joined July 2013
I'm extremely excited to be joining this team next year -- hope you'll join us! https://t.co/2QKRejeegb
@DanielMaMD @DavidRoutmanMD @TheColonelGray @JWilsonOkun @tmalouff @n_laack @MayoRadOnc
🔔🔔Pass it along! We are hiring for a Head & Neck position! https://t.co/ylDxapF5eo
3
6
41
Just a day away from #ASTRO24 & we have exciting news of our own! We are hiring a #radonc for the "breast" team ever! Send your CV to @dshumway (shumway.dean@mayo.edu) so we can chat at ASTRO! & apply 👇 https://t.co/nU1qU6tB5l
@KimCorbinMD @tmalouff @MayElbannaMDPhD
0
3
5
A great place to train!
Please come join us and learn about all that we have to offer! #radonc
0
0
6
Exciting talk by All-Star @MayoRadOnc resident Daniel Ebner on stereotactic proton therapy and immunotherapy for recurrent H&N cancer at @PTCOGNA 9th Annual Meeting!
0
4
21
Only managed to find about half of team @radonc_OU but we’ve got residents, therapy, med phys, and clinical faculty all repping strong this year! #ASTRO23
3
1
23
Calling all rad oncs, educators, and more! Join us for our next @RadiologyACR Webinar: Diversity, Equity, and Inclusion in Radiation Oncology Aug. 16 | 5–6:30pm ET Link to register: https://t.co/HMSfubt1zL
0
16
51
Great podcast that tells you everything you need to know about how to radiate recurrent/refractory lymphoma in the setting of transplant or CAR-T. Direct link at: https://t.co/CpdmyjBrQA
@belinda_campbe @MarioLevis82 @MayoCancerCare @ILROGTeam
3
13
29
🚨@Haematologica: Consolidative RT (cRT) vs observation for residual disease/FDG-activity on day+30 post-CART? cRT alters pattern of relapse➡️ improves local recurrence-free survival (2yr 100% vs 31%)➡️ improves progression-free survival (2yr 73% vs 37%) https://t.co/Vya8b9eyQ1
3
38
89
Congratulations to our resident @AaronBushMD for being selected to be apart of Mayo Clinic GME's Clinician Educator Pathway from a very competitive pool. This is a huge achievement and look forward to seeing all the great things you will accomplish this year! #radonc @ARRO_org
2
4
24
OU Health Stephenson Cancer Center Researcher Leads Global Study Investigating Immunotherapy Drugs for People Living With Cancer and HIV https://t.co/S166l7tFU2
ouhealth.com
Oncologists treating patients who are living with both cancer and HIV have historically lacked scientific data about whether immunotherapy drugs will be effective. A researcher at OU Health Stephen...
0
7
9
An awesome place to rotate and do residency! Highly recommend checking it out as a medical student.
A #radonc away rotation @MayoClinicFlorida means a month to explore the best of Jacksonville, FL: our campus, outstanding faculty, & what residency in sunshine state really feels like! 🌴☀️🌊 🚨 Apply soon via VSLO or email MCCMSVISITORS@mayo.edu #match2024🚨
1
0
8
Financial Toxicity in #Cancer Care: Implications for Clinical Care and Potential Practice Solutions. https://t.co/oaMTJd4e8o
@ASCO @JCO_ASCO @JCOOP_ASCO @ShankaranVeena
#FinancialToxicity #PallOnc #CostsofCare @CostsofCare
0
12
42
Thank you @QuadShotNews for highlighting our study! The modern effective neoadj targeted therapies for Her2+ BC trigger the curiousity to explore warranted adjuvant treatments. Our analysis hopefully gives some insight on this topic as we all eagerly wait for randomized data.
0
2
5
#BlackHistoryMonth is a time to honor the past, celebrate the present & look to the future. This month we spotlight #cancer leaders, such as Dr. Jerry Jaboin. https://t.co/m1zzoOXHJK
@drjcanJJ
3
9
54
Evaluation of proton therapy reirradiation for patients with recurrent HNSCCC Congratulations to @AnnaLeeMDMPH- PT in a previously irradiated area of the head and neck may live longer than photon-based reirradiation @MDAndersonNews @imrtlee @naptprotons https://t.co/iv7N1CrOO4
jamanetwork.com
This cohort study of patients with head and neck squamous cell carcinoma examines the outcomes and toxic effects associated with proton therapy reirradiation for patients with head and neck squamous...
5
17
52
2
13
56